Regulation of nerve growth factor by anti-inflammatory drugs, a steroid, and a selective cyclooxygenase 2 inhibitor in human intervertebral disc cells stimulated with interleukin-1

Spine

Volumn 38, Issue 17, 2013, Pages 1466-1472

  Alimasi, Wuqikun ^a   Sawaji, Yasunobu ^a   Endo, Kenji ^a   Yorifuji, Makiko ^a   Suzuki, Hidekazu ^a   Kosaka, Taiichi ^a   Shishido, Takaaki ^a   Yamamoto, Kengo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

infl ammation; innervation; intervertebral disc; low back pain; nerve growth factor; nonsteroidal anti infl ammatory drugs; PGE 2; prostaglandin; selective COX 2 inhibitor; steroid

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 1; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NERVE GROWTH FACTOR; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; CARTILAGE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERVERTEBRAL DISK; LOW BACK PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84882449781     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318294edb1     Document Type: Article

References (53)

1. Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008;8:8-20.
2. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
3. Lewin GR, Ritter AM, Mendell LM. Nerve growth factorinduced hyperalgesia in the neonatal and adult rat. J Neurosci 1993;13:2136-48.
4. Woolf CJ, Ma QP, Allchorne A, et al. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in infl ammation. J Neurosci 1996;16:2716-23.
5. Micera A, Vigneti E, Pickholtz D, et al. Nerve growth factor displays stimulatory effects on human skin and lung fi broblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162-7.
6. Pincelli C, Haake AR, Benassi L, et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affi nity receptor (TRK): a role for BCL-2. J Invest Dermatol 1997;109:757-64.
7. Iannone F, De Bari C, Dell'Accio F, et al. Increased expression of nerve growth factor (NGF) and high affi nity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxford) 2002;41:1413-8.
8. Korsching S. The neurotrophic factor concept: a reexamination. J Neurosci 1993;13:2739-48.
9. Levi-Montalcini R, Dal Toso R, della Valle F, et al. Update of the NGF saga. J Neurol Sci 1995;130:119-27.
10. Freemont AJ, Peacock TE, Goupille P, et al. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 1997;350:178-81.
11. Takahashi K, Aoki Y, Ohtori S. Resolving discogenic pain. Eur Spine J 2008;17 ( suppl 4 ): 428-31.
12. Coppes MH, Marani E, Thomeer RT, et al. Innervation of "painful" lumbar discs. Spine 1997;22:2342-9;discussion 9-50.
13. Abe Y, Akeda K, An HS, et al. Proinfl ammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells. Spine 2007;32:635-42.
14. Roelofs PDDM, Deyo RA, Koes BW, et al. Non-steroidal antiinfl ammatory drugs for low back pain. Cochrane Database Syst Rev (Online) 2008:CD000396.
15. Shi S, Klotz U. Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol 2008;64:233-52.
16. Abdi S, Datta S, Trescot AM, et al. Epidural steroids in the management of chronic spinal pain: a systematic review. Pain Phys 2007;10:185-212.
17. Wang D-L, Jiang S-D, Dai L-Y. Biologic response of the intervertebral disc to static and dynamic compression in vitro. Spine 2007;32:2521-8.
18. Sawaji Y, Hynes J, Vincent T, et al. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008;58:3498-509.
19. Wang JY, Baer AE, Kraus VB, et al. Intervertebral disc cells exhibit differences in gene expression in alginate and monolayer culture. Spine 2001;26:1747-51;discussion 52.
20. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 2007;282:11613-7.
21. Coppes MH, Marani E, Thomeer RT, et al. Innervation of annulus fi brosis in low back pain. Lancet 1990;336:189-90.
22. Shinohara H. Lumbar disc lesion, with special reference to the histological signifi cance of nerve endings of the lumbar discs. Nihon Seikeigeka Gakkai Zasshi 1970;44:553-70.
23. Ozawa T, Ohtori S, Inoue G, et al. The degenerated lumbar intervertebral disc is innervated primarily by peptide-containing sensory nerve fi bers in humans. Spine 2006;31:2418-22.
24. Freemont AJ, Watkins A, Le Maitre C, et al. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002;197:286-92.
25. Aoki Y, Ohtori S, Takahashi K, et al. Innervation of the lumbar intervertebral disc by nerve growth factor-dependent neurons related to infl ammatory pain. Spine 2004;29:1077-81.
26. Aoki Y, Takahashi Y, Takahashi K, et al. Sensory innervation of the lateral portion of the lumbar intervertebral disc in rats. Spine J 2004;4:275-80.
27. Lotz JC, Ulrich JA. Innervation, infl ammation, and hypermobility may characterize pathologic disc degeneration: review of animal model data. J Bone Joint Surg Am 2006;88 ( suppl 2 ): 76-82.
28. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005;7:R732-45.
29. Weiler C, Nerlich AG, Bachmeier BE, et al. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine (Phila Pa 1976) 2005;30:44-53;discussion 4.
30. Burke JG, G Watson RW, Conhyea D, et al. Human nucleus pulposis can respond to a pro-infl ammatory stimulus. Spine 2003;28:2685-93.
31. Ohtori S, Suzuki M, Koshi T, et al. Proinfl ammatory cytokines in the cerebrospinal fl uid of patients with lumbar radiculopathy. Eur Spine J 2011;20:942-6.
32. Ohtori S, Miyagi M, Eguchi Y, et al. Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study. Spine 2012;37:439-44.
33. Ohtori S, Miyagi M, Eguchi Y, et al. Effi cacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. [published online ahead of print February 21, 2012] Eur Spine J 2012;21:2079-84.
34. Maeda S, Kokubun S. Changes with age in proteoglycan synthesis in cells cultured in vitro from the inner and outer rabbit annulus fi brosus. Responses to interleukin-1 and interleukin-1 receptor antagonist protein. Spine 2000;25:166-9.
35. Purmessur D, Freemont AJ, Hoyland JA. Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res Ther 2008;10:R99.
36. Lindholm D, Heumann R, Hengerer B, et al. Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fi broblasts. J Biol Chem 1988;263:16348-51.
37. Vige X, Costa E, Wise BC. Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fi broblast growth factor in primary cultures of rat astrocytes. Mol Pharmacol 1991;40:186-92.
38. Buenaventura RM, Datta S, Abdi S, et al. Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Phys 2009;12:233-51.
39. Saklatvala J. Glucocorticoids: do we know how they work Arthritis Res 2002;4:146-50.
40. Caput D, Beutler B, Hartog K, et al. Identifi cation of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying infl ammatory mediators. Proc Natl Acad Sci USA 1986;83:1670-4.
41. Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 1995;20:465-70.
42. Shaw G, Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-67.
43. D'Melo SR, Heinrich G. Nerve growth factor gene expression: Involvement of a downstream AP-1 element in basal and modulated transcription. Mol Cell Neurosci 1991;2:157-67.
44. Ullrich A, Gray A, Berman C, et al. Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature 1983;303:821-5.
45. Koes BW, van Tulder MW, Ostelo R, et al. Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine 2001;26:2504-13;discussion 13-4.
46. van Tulder M, Becker A, Bekkering T, et al. Chapter European guidelines for the management of acute nonspecifi c low back pain in primary care. Eur Spine J 2006;15 ( suppl 2 ): S169-91.
47. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-infl ammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55.
48. Henschke N, Maher CG, Refshauge KM, et al. Prognosis in patients with recent onset low back pain in Australian primary care: inception cohort study. BMJ 2008;337:a171.
49. Vassiliou E, Jing H, Ganea D. Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 2003;223:120-32.
50. Jing H, Vassiliou E, Ganea D. Prostaglandin E2 inhibits production of the infl ammatory chemokines CCL3 and CCL4 in dendritic cells. J Leukoc Biol 2003;74:868-79.
51. Nishitani K, Ito H, Hiramitsu T, et al. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes. J Cell Biochem 2010;109:425-33.
52. Toyomoto M, Ohta M, Okumura K, et al. Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett 2004;562:211-5.
53. Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci 2003;74:143-53.